Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents

Leukemia

Volumn 13, Issue 7, 1999, Pages 1062-1070

  Zhu, J ^a   Guo, W M ^a   Yao, Y Y ^a   Zhao, W L ^a   Pan, L ^a   Cai, X ^a   Ju, B ^a   Sun, G L ^a   Wang, H L ^a   Chen, S J ^a   Chen, G Q ^a   Caen, J ^b   Chen, Z ^a   Wang, Z Y ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b Institut des Vaisseaux et du Sang   (France)

Author keywords

APL coagulopathy; As2O3; ATRA; DNR; PML RAR ; Tissue factor

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; FIBRINOGEN; MESSENGER RNA; RETINOIC ACID; RETINOIC ACID RECEPTOR; THROMBOPLASTIN;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS;

EID: 20244379554     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401448     Document Type: Article

References (39)

1. Kao FT, Hartz J, Norton R, Nemerson Y, Carson SD. Regional assignment of human tissue factor gene (F3) to chromosome 1p21-p22. Somat Cell Mol Genet 1988; 14: 407-410.
2. Mackman N, Norrissey JH, Fowler B, Edginton TS. Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry 1989; 28: 1755-1762.
3. Darke TA, Morrissey JH, Edington TS. Selective cellular expression of tissue factor in human tissues: implications for the disorders of hemostasis and thrombosis. Am J Pathol 1989; 134: 1087-1097.
4. Fleck RA, Rao LVM, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990; 59: 421-437.
5. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-2843.
6. Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-5264.
7. Komiyama Y, Pedersen AH, Kisiel W. Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor. Biochemistry 1990; 29: 9418-9425.
8. Drake TA, Chen J, Chang A, Taylor FB Jr. Expression of tissue factor, throbomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 1993; 142: 1458-1470.
9. Bauer KA, Rosenberg RD. Thrombin generation in acute promyelocytic leukemia. Blood 1984; 64: 791-796.
10. Edginton TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66: 67-79.
11. Mueller BM, Ruf W. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest 1998; 101: 1372-1378.
12. Ollivier V, Bentolila S, Chabbat J, Hakim J, de Prost D. Tissue factor-dependent vascular endothelial production by human fibroblast in response to activated factor VII. Blood 1998; 91: 2698-2703.
13. Parry GC, Erlich JH, Cameliet P, Luther T, Mackman N. Low level of tissue factor are compatible with development and hemostasis in mice. J Clin Invest 1998; 101: 560-569.
14. Warrell RP Jr, de The H, Wang ZY. Acute promyelocytic leukemia. New Engl J Med 1993; 329: 177-189.
15. Polliac A. Acute promyelocytic leukemia with disseminated intravascular coagulation. Am J Clin Pathol 1971; 56: 155-161.
16. Huang ME, Ye HC, Chen SR, Chai JR, Lu HX, Zhao L, Gu LJ, Wang ZY. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567-572.
17. Dombret H, Scrobohaci ML, Ghorra P, Zini JM, Daniel MT, Castaigne S, Degos L. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment. Leukemia 1993; 7: 2-9.
18. Tallman MS. Deciphering the pathogenesis of coagulation dysfunction in leukemia. Leukemia Res 1996; 20: 13-16.
19. Barbui T, Finazzi G, Falanga A. The impact of all-trans retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood 1998; 91: 3093-3102.
20. Koyama T, Hirosawa S, Kawamata N, Tohda S, Aoki N. All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells. Blood 1994; 84: 3001-3009.
21. Falanga A, Consonni R, Marchetti M, Mielicki WP, Rambaldi A, Lanotte M, Gordon SG, Barbui T. Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans retinoic acid. Leukemia 1994; 8: 156-159.
22. Saito T, Koyama T, Nagata K, Kamiyama R, Hirosawa S. Anticoagulant effects of retinoic acids on leukemia cells. Blood 1996; 87: 657-665.
23. Taylor FB Jr, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edginton TS. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991; 33: 127-134.
24. Falanga A, Marchetti M, Ciovanelli S, Barbui T. All-trans retinoic acid counteracts endothelial cell procoagulant activity induced by a human promylocytic leukemia-derived cell line (NB4). Blood 1996; 87: 613-617.
25. De Stefane V, Teofili L, Sica S, Mastrangelo S, Di Mario A, Ruttella S, Salutari P, Rumi C, d'Onofrio G, Leone G. Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia. Blood 1995; 86: 3535-3541.
26. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical cord veins. Identification and immunological criteria. J Clin Invest 1973; 52: 2745-2756.
27. Potegens AJG, Lubesen NH, van Altena G, Schoenmakers JGG, Ruiter DJ, de Wall RMW. Measurement of tissue factor mRNA levels in human endothelial cells by quantitative RT-PCR assay. Thromb Haemost 1994; 71: 208-213.
28. Shibakura M, Koyama T, Saito T, Shudo K, Miyasaka N, Kamiyama R, Hirosawa S. Anticoagulant effects of synthetic retinoids mediated via different receptors on human leukemia and umbilical vein endothelial cells. Blood 1997; 90: 1545-1551.
29. Morrissey JH, Fahrai H, Edgington TS. Molecular cloning of cDNA for tissue factor, the cellular receptor for the initiation of coagulation protease cascade. Cell 1987; 50: 129-135.
30. Hsu HC, Yang K, Khharbanda S, Clinton S, Datta R, Stone RM. All-trans retinoic acid induces monocyte growth factor receptor (c-fms) gene expression in HL-60 leukemia cells. Leukemia 1992; 7: 458-462.
31. Zhu J, Koken MHM, Quignon F, Chelbi-Alix MK, Degos L, Wang ZY, Chen Z, de The H. Arsenic-induced PML targeting on to nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc Natl Acad Sci USA 1997; 94: 3978-3983.
32. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and alteration of PML-RARa/PML protein localization. Blood 1996; 88: 1052-1061.
33. Liu L. DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 1989; 58: 351-375.
34. Fibach F, Treves A, Korenberg A, Rachmilewitz EA. In vitro generation of procoagulant activity by leukemic promyelocytes in response to cytotoxic drugs. Am J Hematol 1985; 20: 257-265.
35. Kalantry S, Delva L, Gaboli M, Gandini D, Giorgio M, Hawe N, He LZ, Peruzzi D, Rivi R, Tribuli C, Wang ZG, Zhang H, Pandolfi PP. Gene rearrangements in the molecular pathogenesis of acute promyelocytic leukemia. J Cell Physiol 1997; 173: 288-296.
36. Mackman N, Brand K, Edginton TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor in THP-1 monocytic cells requies both activator protein 1 and nuclear factor kB binding sites. J Exp Med 1991; 174: 1517-1526.
37. Vallian S, Gaken JA, Gingold EB, Kouzarides T, Chang KS, Farzanch F. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein. Oncogene 1998; 16: 2843-2856.
38. Gianni M, Koken MHM, Chelbi-Alix MK, Benoit G, Lanotte M, Chen Z, de Thé H. Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells. Blood 1998; 91: 4330-4310.
39. Brown D, Kogan S, Ladasse E, Weissman I, Alcalay M, Pelicci PG, Atwater S, Bishop M. A PMLRARa transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci USA 1997; 94: 2551-2556.